Toggle sidebar
定价
登录
obesity and associated comorbidities
搜索文档
Novo Nordisk To Buy Akero Therapeutics for $4.7 Billion
WSJ
·
2025-10-09 18:39
收购战略 - 公司收购行为旨在支持其开发糖尿病、肥胖症及其相关并发症治疗药物的战略 [1]
Company acquisition
Pharmaceuticals
Medicines for diabetes
obesity and associated comorbidities
Company acquisition
Pharmaceuticals
Medicines for diabetes
obesity and associated comorbidities